Close Menu

Precision Oncology News

Angiosarcoma Research, Drug Trials Get Boost From Grassroots Effort Collecting Samples From Patients

Premium

Exosome-Based Treatment Targeting KRAS G12D-Mutated Pancreatic Cancer to Enter Human Studies Next Month

Premium

Mutated KRAS protein has been notoriously difficult to target with drugs, but MD Anderson researchers are trying to get at KRAS mRNA using exosomes.

Profiling of Osteosarcomas Uncovers Numerous Mechanisms Blocking Immune Checkpoint Inhibitor Therapy Response

The analysis also suggested ways to outwit these mechanisms based on the degree of immune cell infiltration into the tumor. 

Cancer, Pathology Organizations Developing Clinical Guidelines for MMR, MSI Testing

The groups have written draft recommendations and are now asking for public comment from pathologists and other stakeholders.

What's Popular?

  1. Genetron Health, InnoCare Partner on Cancer Clinical Trial Testing, CDx Development

  2. Cancer, Pathology Organizations Developing Clinical Guidelines for MMR, MSI Testing

  3. CytoDyn Gains IRB Approval to Start Phase II Basket Trial for Leronlimab

  4. High Expression of Alternative Checkpoints, CD68 Associated With Resistance to Anti-PD1 Therapy

  5. Exosome-Based Treatment Targeting KRAS G12D-Mutated Pancreatic Cancer to Enter Human Studies Next Month

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.